About Multiple Sclerosis

Multiple Sclerosis is a chronic, incurable, and unpredictable disease of the central nervous system (the brain, optic nerves, and spinal cord). MS is characterized by the...

Support Our Work (pictured above: Tisch MSRCNY Research Team)

The Tisch MS Research Center of New York is dedicated to finding the cause of and cure for multiple sclerosis. Tisch MS focuses on translational research, bringing...

Facilities

The Tisch MS Research Center is equipped with the latest in research equipment and technology in order to conduct cutting-edge research for the benefit of people with MS...

Research

At Tisch MS we have several ongoing research projects.  Browse this section to learn more about each project.

FDA Approves Neural Stem Cell Trial

(pictured above Dr. Saud A. Sadiq and Dr. Violaine K. Harris)

Repair Strategies in MS

There are no existing therapies that are capable of repairing the myelin and nerve damage that exist in MS. Dr. Harris and her team focused on adult stem cells from the...

The Tisch MS Research Center of New York is dedicated to finding the cause and cure of multiple sclerosis

Tisch MS News

Dr. Violaine Harris and Dr. Saud A. Sadiq co-authored a review entitled “Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status and this has been accepted for publication in the Journal  Molecular Diagnosis and Therapy.

"Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status"

The journal Neurology® Neuroimmunology and Neuroinflammation accepted a paper by lead author Dr. Fozia Mir entitled, “Cerebrospinal fluid isoprostane levels are a biomarker of oxidative stress in multiple sclerosis.” The paper is authored by Dr. Mir, Donald Lee, Hetal Ray, and Saud A. Sadiq, MD and in it the team has identified a lipid, 8-iso-prostaglandinF2α (8-iso-PGF2α), as a biomarker for disease activity and oxidative stress in the...

Real Time Analytics